Le Lézard
Classified in: Health
Subjects: RCL, CFG

Public advisory - Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site


OTTAWA, ON, June 15, 2024 /CNW/ -

Summary

Baxter Connector (CNW Group/Health Canada (HC))

Affected products

Product 

DIN

Lot 

Expiry 

Dianeal PD4 2.5% Dextrose 3,000 mL

00865109

W4C09T0

03/31/2026

Dianeal PD4 2.5% Dextrose 5,000 mL

00865109

W4B26T4

W4B29T1

W4C07T1

W4C18T2

02/28/2026

02/28/2026

03/31/2026

03/31/2026

Physioneal 40 2.27% Glucose 2,500 mL

02247722

W4B26T2

02/28/2025

Issue

Vantive ULC (a subsidiary of Baxter Corporation) is recalling certain lots of Dianeal and Physioneal peritoneal dialysis solutions because of possible leakage at the connection site . The affected lots were distributed in Canada between March 6, 2024, and May 29, 2024.

Dianeal and Physioneal are sterile peritoneal dialysis solutions used in hospitals and home settings to treat patients whose kidneys are not working properly.

Products with leakage at the connection site  may become contaminated, exposing patients to microbial contamination and an increased risk of peritonitis. Peritonitis is when the thin layer of tissue inside the abdomen, called the peritoneum, becomes inflamed. Symptoms of peritonitis include fever and chills, belly pain or tenderness, feeling bloated, upset stomach and vomiting, loss of appetite, diarrhea or constipation, extreme fatigue and confusion. Peritonitis can result in death.

Health Canada is monitoring the company's recall, and its implementation of any necessary corrective and preventative actions to prevent this issue from reoccurring. The Department will inform the public if any new health risks are identified.

What you should do

      Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

at 06:05
Avallano is launching ProtocolCopilottm, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols....

at 06:00
The RONA Foundation, which oversees the philanthropic activities of RONA inc., one of Canada's leading home improvement retailers operating and servicing some 425 corporate and affiliated stores, will present a total of $1,000,000 to seven non-profit...

at 06:00
July 16th, 2024 Advanced Orthodontics is pleased to unveil its new website at https://www.theadvancedortho.com. The website is user and mobile-friendly, containing essential information to help patients make...

at 05:30
Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced positive results of its first-in-human...

at 05:30
The global esophageal cancer market stood at US$ 2.2 billion in 2023, and the global market is projected to reach US$ 4.6 billion in 2034. The esophageal cancer market is anticipated to expand at a CAGR of 6.7% between 2024 and 2034. The esophageal...

at 05:17
Second Quarter 2024 Total revenue increased 12 per cent, 11 per cent at constant exchange rates, (CER), to SEK 5,442 M (4,872)Haematology revenue increased 13 per cent at CER to SEK 3,866 M (3,430), reflecting growth in all medicines, mainly driven...



News published on and distributed by: